These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Role of Presepsin (sCD14-ST) and the CURB65 scoring system in predicting severity and outcome of community-acquired pneumonia in an emergency department. Liu B, Yin Q, Chen YX, Zhao YZ, Li CS. Respir Med; 2014 Aug; 108(8):1204-13. PubMed ID: 24931899 [Abstract] [Full Text] [Related]
4. Prognostic Value of Plasma Presepsin and Pneumonia Severity Index in Patients with Community-Acquired Pneumonia in the Emergency Department. Lee KR, Hong DY, Paik JH, Jung HM. Medicina (Kaunas); 2022 Oct 22; 58(11):. PubMed ID: 36363461 [Abstract] [Full Text] [Related]
6. Prognostic performance of MR-pro-adrenomedullin in patients with community acquired pneumonia in the Emergency Department compared to clinical severity scores PSI and CURB. Legramante JM, Mastropasqua M, Susi B, Porzio O, Mazza M, Miranda Agrippino G, D Agostini C, Brandi A, Giovagnoli G, Di Lecce VN, Bernardini S, Minieri M. PLoS One; 2017 Oct 22; 12(11):e0187702. PubMed ID: 29161297 [Abstract] [Full Text] [Related]
7. Presepsin as a novel diagnostic biomarker for differentiating active pulmonary tuberculosis from bacterial community acquired pneumonia. Qi ZJ, Yu H, Zhang J, Li CS. Clin Chim Acta; 2018 Mar 22; 478():152-156. PubMed ID: 29289622 [Abstract] [Full Text] [Related]
8. Admission lactate predicts poor prognosis independently of the CRB/CURB-65 scores in community-acquired pneumonia. Frenzen FS, Kutschan U, Meiswinkel N, Schulte-Hubbert B, Ewig S, Kolditz M. Clin Microbiol Infect; 2018 Mar 22; 24(3):306.e1-306.e6. PubMed ID: 28710027 [Abstract] [Full Text] [Related]
9. Utility of two biomarkers for directing care among patients with non-severe community-acquired pneumonia. España PP, Capelastegui A, Bilbao A, Diez R, Izquierdo F, Lopez de Goicoetxea MJ, Gamazo J, Medel F, Salgado J, Gorostiaga I, Quintana JM, Population Study of Pneumonia (PSoP) Group. Eur J Clin Microbiol Infect Dis; 2012 Dec 22; 31(12):3397-405. PubMed ID: 23010902 [Abstract] [Full Text] [Related]
12. Usefulness of consecutive biomarkers measurement in the management of community-acquired pneumonia. Lacoma A, Rodríguez N, Prat C, Ruiz-Manzano J, Andreo F, Ramírez A, Bas A, Pérez M, Ausina V, Domínguez J. Eur J Clin Microbiol Infect Dis; 2012 May 22; 31(5):825-33. PubMed ID: 21870054 [Abstract] [Full Text] [Related]
13. [Diagnostic and prognostic power of biomarkers to improve the management of community acquired pneumonia in the emergency department]. Julián-Jiménez A, Timón Zapata J, Laserna Mendieta EJ, Sicilia-Bravo I, Palomo-de Los Reyes MJ, Cabezas-Martínez A, Laín-Terés N, Estebaran-Martín J, Lozano-Ancín A, Cuena-Boy R. Enferm Infecc Microbiol Clin; 2014 Apr 22; 32(4):225-35. PubMed ID: 24182623 [Abstract] [Full Text] [Related]
16. Presepsin and procalcitonin as biomarkers of systemic bacterial infection in patients with rheumatoid arthritis. Tsujimoto K, Hata A, Fujita M, Hatachi S, Yagita M. Int J Rheum Dis; 2018 Jul 22; 21(7):1406-1413. PubMed ID: 27291096 [Abstract] [Full Text] [Related]
19. The alveolar-arterial gradient, pneumonia severity scores and inflammatory markers to predict 30-day mortality in pneumonia. Avci S, Perincek G. Am J Emerg Med; 2020 Sep 22; 38(9):1796-1801. PubMed ID: 32739850 [Abstract] [Full Text] [Related]
20. Elevated Red Blood Cell Distribution Width Combined White Blood Cell in Peripheral Blood Routine Have a Better Sensitivity than CURB-65 Scores in Predicting ICU Admission and Mortality in Adult Community-Acquired Pneumonia Patients. Ge YL, Liu CH, Rana MA, Zhu XY, Wang N, Xu J, Su CS, Li HL, Li ZZ, Hassan RA, Li HL, Zhang HF, Zhang X, Yu HL, Zhang JB, Fu AS, Wang HY. Clin Lab; 2019 Mar 01; 65(3):. PubMed ID: 30868855 [Abstract] [Full Text] [Related] Page: [Next] [New Search]